On 12 February, Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), announced that AbbVie has submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval for AbbVie’s investigational, once-daily dosed, all-oral, ribavirin (RBV)-free and interferon (IFN)-free, 12-week, two direct-acting antiviral treatment consisting of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r). On Tuesday shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) closed at $32.95.
On 12 February, Verastem, Inc. (NASDAQ:VSTM), announced that VS-5584 has received orphan drug designation from the U.S. Food and Drug Administration for use in the treatment of mesothelioma. Verastem, Inc. (NASDAQ:VSTM) in last trading activity increased 3.15% to close at $8.18. Company weekly performance is 7.63% while its quarterly performance stands at -11.28%. Verastem, Inc. (NASDAQ:VSTM) is -48.39% away from its 52 week high.
Exeter Resource Corporation (NYSE MKT:XRA) is pleased to announce further positive results from the expanded water exploration drilling program for its Caspiche gold-copper project in northern Chile. The Company believes it has discovered an extensive, new, subterranean aquifer with no apparent connection to surface water, or other aquifers in the area. On last trading day Exeter Resource Corporation (NYSEMKT:XRA) increased 1.78% to close at $0.52. Its volatility for the week is 4.50% while volatility for the month is 5.14%. XRA’s EPS growth for past 5 years was 1.10%. Exeter Resource Corporation (NYSEMKT:XRA) monthly performance is -14.40%.
Hansen Medical, Inc. (NASDAQ: HNSN), announced it will exhibit its Magellan™ Robotic System at the 40th Annual Society of Interventional Radiology (SIR) Scientific Meeting March 1 – March 4 at the Georgia World Congress Center in Atlanta, GA. Hansen Medical, Inc. (NASDAQ:HNSN) has 16.20% insider ownership while its institutional ownership stands at 34.20%. In last trading activity company’s stock closed at $1.07.
Lake Shore Bancorp, Inc. (NASDAQ:LSBK) Board of Directors approved a $0.07 per share cash dividend on its common stock, payable on March 10, 2015, to shareholders of record as of February 19, 2015. On last trading day Lake Shore Bancorp Inc. (NASDAQ:LSBK) remains unchanged to close at $13.50. Its volatility for the week is 1.42% while volatility for the month is 1.02%. LSBK’s sales growth for past 5 years was -1.90% and its EPS growth for past 5 years was 8.30%. Lake Shore Bancorp Inc. (NASDAQ:LSBK) monthly performance is -0.66%.